Nutrition and Neurological Development of Very Preterm Infants
NCT ID: NCT02184650
Last Updated: 2025-11-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
206 participants
OBSERVATIONAL
2014-07-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* the quantity of mother's milk and duration and breastfeeding
* the intake of polyunsaturated fatty acids and iron during hospitalizations
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nutrition Protocol and Premature Infants' Growth
NCT03217045
Initial Nutritional Strategy and Stature-level Growth During the Neonatal Period of Children Born Moderately Premature
NCT03662503
Early Family Based Intervention in Preterm Infants
NCT02415530
Enhanced Nutrition for Preterm Infants
NCT03238768
Assessment of the Mental State of Parents of Premature Children and Impact on Neurodevelopment of the Child
NCT04827225
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the previous study EPINUTRI (NCT01486173), the development of infants was evaluated until the age of 1 year. EPINUTRI\_3 is the follow-up of EPINUTRI until the age of 3 years.
The aim of EPINUTRI\_3 study is to determine the association between lipid intake during hospitalization in neonatology department of preterm infants born with a GA \< 32 weeks.
The secondary objective is :
\- to evaluate the association between these factors and communication, developmental and social-emotional delays with the test " Ages and Stages questionnaire " (ASQ) at 3 years of age.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Premature infants
Premature infants with a GA \< 32 weeks
Premature infants with a GA < 32 weeks
At 3 years of age: ASQ (filled in by parents)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Premature infants with a GA < 32 weeks
At 3 years of age: ASQ (filled in by parents)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Non opposition of the parents for the collection of clinical and nutritional data
Exclusion Criteria
3 Years
3 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
URC-CIC Paris Descartes Necker Cochin
OTHER
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexandre Lapillonne, M.D, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Hôpital Necker Assistance Publique-Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Necker Assistance Publique- Hôpitaux de Paris
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Pierrat V, Marchand-Martin L, Marret S, Arnaud C, Benhammou V, Cambonie G, Debillon T, Dufourg MN, Gire C, Goffinet F, Kaminski M, Lapillonne A, Morgan AS, Roze JC, Twilhaar S, Charles MA, Ancel PY; EPIPAGE-2 writing group. Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study. BMJ. 2021 Apr 28;373:n741. doi: 10.1136/bmj.n741.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID RCB 2014-A00941-46
Identifier Type: OTHER
Identifier Source: secondary_id
NI 13016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.